相关实验视频
Updated: Jun 2, 2025

04:38
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
271
在非囊性纤维化支气管切除症的成年人中,细分切除术与叶片切除术的结果
José de Sá Moraes Neto1, Isabele Alves Chirichela1, Alessandro Wasum Mariani1
1. Departamento de Cirurgia Torácica, Instituto do Coracao, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, BR.
概括
细分切除术为支气管切除术患者提供了与带切除术相似的疾病控制,并发症明显减少,住院时间缩短. 早期的手术候选人识别可以实现护体内膜节约切除,以获得更好的结果.
科学领域:
- 胸部外科手术 胸部外科手术
- 肺部医学 肺部医学
- 手术瘤学手术瘤学
背景情况:
- 手术切除是对严重支气管切除症的首要治疗方法,这种支气管切除症对医疗管理无反应.
- 亚叶切除术 (细分切除术) 和叶叶切除术 (叶叶切除术) 是外科选择.
- 在非囊性纤维化支气管切除症中比较细分切除和叶片切除疗效至关重要.
研究的目的:
- 评估细分切除术与非囊性纤维化支气管切除术的疗效.
- 为了比较分片切除和分片切除之间的手术内并发症和术后结果.
主要方法:
- 在2019-2023年间进行细分切除或分叶切除的患者的回顾性分析.
- 评估手术中的并发症 (如出血,休克,呼吸系统不稳定).
- 术后结果的评估:住院,ICU住院和疾病复发.
主要成果:
- 两组之间主要的手术内并发症没有显著差异 (p > 0.999).
- 分段切除组的整体并发症明显减少 (p = 0.016).
- 分段切除术导致住院时间缩短 (5 vs. 16天; p = 0.027) 和ICU住院时间缩短 (1 vs. 7天; p = 0.006).
- 细分切除术和分叶切除术之间的疾病复发率相似 (p = 0.541).
结论:
- 帕伦基马节约细分切除术为部分支气管切除症患者提供了与带切除术可比的疾病控制.
- 分段切除术导致术后结果的改善,包括减少住院和ICU停留时间.
- 早期识别手术候选人可以进行护理膜节约切除,优化患者的康复.
相关概念视频
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
173
Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
173
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139

